獣医診断市場 – 2030年までの世界予測

本市場調査は、獣医診断市場を様々なセグメントにわたって網羅しています。製品、用途、技術、動物種、エンドユーザー、地域別に、様々なセグメントにおける市場規模と成長の可能性を推定することを目的としています。また、主要プレーヤーの詳細な競合分析、企業概要、製品および事業内容に関する主要な考察、最近の動向、主要な市場戦略も含まれています。

世界の獣医診断市場は、2025年の36億8,000万米ドルから2030年には53億6,000万米ドルに達し、予測期間中に7.8%の年平均成長率（CAGR）で成長すると予測されています。市場成長の主な原動力は、特に都市部および高所得地域における動物の飼育と飼育の増加です。ペットの飼い主は、予防診断、定期的な健康診断、疾病モニタリングなど、質の高い動物医療を求めています。鳥インフルエンザ、レプトスピラ症、ブルセラ症、狂犬病といった人獣共通感染症の蔓延も、市場の成長に貢献しています。リアルタイムPCR、次世代シーケンシング（NGS）、マイクロフルイディクス、ポータブル診断分析装置、人工知能といった技術の進歩により、診断検査の精度、速度、アクセス性が向上しています。

The global veterinary diagnostics market is projected to reach USD 5.36 billion by 2030 from USD 3.68 billion in 2025, at a CAGR of 7.8% during the forecast period. A key growth driver for market growth includes rising ownership and the domestication of animals, particularly in urban and high-income regions. Pet owners require high-quality animal medical care, including preventive diagnostics, routine health screenings, and disease monitoring. The increasing prevalence of zoonotic diseases, such as avian influenza, leptospirosis, brucellosis, and rabies, also contributes to the market’s growth. Technological advancements in real-time PCR, next-generation sequencing (NGS), microfluidics, portable diagnostic analyzers, and artificial intelligence are enhancing the accuracy, speed, and accessibility of diagnostic testing.

By product, the instruments segment is projected to grow at the highest CAGR during the forecast period.

By product, the market is segmented into consumables and instruments. The instruments segment is projected to grow at the highest CAGR during the forecast period. The instruments include diagnostic test analyzers and portable analyzers. These analyzers measure the physiologically significant substances present in body fluids (blood, serum, plasma, and urine) and feces of animals. Increasing technological advancements and the development of AI-enabled instruments for veterinary diagnostics are expected to fuel the market adoption in this segment during the forecast period.

By technology, the molecular diagnostics segment is estimated to grow at the highest CAGR during the forecast period.

By technology, the molecular diagnostics segment is expected to grow at the highest CAGR during the forecast period. This segment includes PCR tests, microarray tests, and nucleic acid sequencing technologies. The high growth rate of this segment is attributed to the increasing incidence of infectious and zoonotic diseases, which further increases the demand for precise and rapid diagnostic solutions. Molecular diagnostics allow the identification of specific pathogens, genetic disorders, and antimicrobial resistance, which is critical for the timely treatment of various diseases. Technological advancements in molecular diagnostic tests, such as PCR and next-generation sequencing, also contribute to the market’s growth.

By region, the Asia Pacific market is expected to grow at the highest CAGR during the forecast period.

The market is segmented by region into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to grow at the highest CAGR during the forecast period owing to the rising awareness about animal health, the increasing per capita income, favorable government initiatives for pet adoption, and the increasing production of livestock products in emerging economies. The rising pet ownership in rapidly urbanizing economies such as China, India, Indonesia, and South Korea is also expected to drive the market growth during the forecast period.

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
• By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
• By Region: North America (40%), Europe (25%), the Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

• By Company Type: Veterinary Reference Laboratories (40%), Veterinary Hospitals & Clinics (25%), POC/In-house Testing (20%), and Veterinary Research Institutes & Universities (15%)
• By Designation: Veterinary Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%)
• By Region: North America (40%), Europe (25%), the Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Research Coverage:

The market study covers the veterinary diagnostics market across various segments. It aims to estimate the market size and the growth potential across different segments by product, application, technology, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall veterinary diagnostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

Analysis of key drivers (rise in companion animals, growing demand for products derived from animals, increased zoonotic disease cases, increase in pet insurance, increase in disease control and disease prevention measures), restraints (rising pet cost care and high cost of diagnostic tests), opportunities (high growth potential of emerging economies), and challenges (lack of animal health awareness and shortage of veterinary practitioners) influencing the growth of the veterinary diagnostics market

• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global veterinary diagnostics market. The report analyzes this market by product, application, technology, animal type, end user, and region.
• Product Enhancement/Innovation: Detailed insights into upcoming trends and product launches in the global veterinary diagnostics market.
• Market Development: Comprehensive information on the lucrative emerging markets by product, technology, animal type, application, end user, and region.
• Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the global veterinary diagnostics market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global veterinary diagnostics market.

Table of Contents

1               INTRODUCTION              47

1.1           STUDY OBJECTIVES       47

1.2           MARKET DEFINITION   47

1.2.1        INCLUSIONS & EXCLUSIONS       47

1.2.2        MARKETS & REGIONS COVERED               48

1.2.3        YEARS CONSIDERED      49

1.3           MARKET STAKEHOLDERS            49

1.4           LIMITATIONS    49

1.5           SUMMARY OF CHANGES               50

2               RESEARCH METHODOLOGY       51

2.1           RESEARCH APPROACH  51

2.2           RESEARCH METHODOLOGY DESIGN     51

2.2.1        SECONDARY RESEARCH                52

2.2.1.1    Key data from secondary sources       53

2.2.2        PRIMARY DATA 53

2.2.2.1    Key data from primary sources           54

2.2.2.2    Key industry insights           55

2.3           MARKET SIZE ESTIMATION         56

2.3.1        BOTTOM-UP APPROACH              62

2.4           MARKET BREAKDOWN AND DATA TRIANGULATION                 63

2.5           MARKET SHARE ANALYSIS           64

2.6           RESEARCH ASSUMPTIONS           64

2.6.1        GROWTH RATE ASSUMPTIONS 64

2.7           RISK ASSESSMENT           65

2.8           RESEARCH LIMITATIONS             65

2.8.1        METHODOLOGY-RELATED LIMITATIONS           65

2.8.2        SCOPE-RELATED LIMITATIONS                 65

3               EXECUTIVE SUMMARY  66

4               PREMIUM INSIGHTS       71

4.1           VETERINARY DIAGNOSTICS MARKET OVERVIEW                 71

4.2           ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT & COUNTRY (2024)    72

4.3           VETERINARY DIAGNOSTICS MARKET: REGIONAL MIX                 73

4.4           VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES         73

4.5           VETERINARY DIAGNOSTICS MARKET: DEVELOPED MARKETS VS.

EMERGING ECONOMIES               74

5               MARKET OVERVIEW       75

5.1           MARKET DYNAMICS       75

5.1.1        DRIVERS               76

5.1.1.1    Growth in companion animal population         76

5.1.1.2    Increasing demand for animal-derived food products    78

5.1.1.3    Growing concerns about infectious zoonotic diseases    78

5.1.1.4    Rising demand for pet insurance and growing animal health expenditure            80

5.1.1.5    Increasing number of veterinary practitioners and rising income levels in developed markets 82

5.1.1.6    Growing focus on disease control & prevention measures                 83

5.1.2        RESTRAINTS      83

5.1.2.1    Rising pet care costs             83

5.1.2.2    High cost of veterinary diagnostic tests            84

5.1.3        OPPORTUNITIES              84

5.1.3.1    Growth potential of emerging economies         84

5.1.3.2    Integration of AI & ML        85

5.1.4        CHALLENGES    85

5.1.4.1    Low animal healthcare awareness in emerging countries                 85

5.1.4.2    Shortage of veterinary practitioners in emerging economies                 86

5.2           INDUSTRY TRENDS         87

5.2.1        ADOPTION OF MULTIPLE TEST PANELS               87

5.2.2        OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES             87

5.2.3        GROWING SCALE OF VETERINARY BUSINESSES 88

5.3           TECHNOLOGY ANALYSIS             88

5.3.1        KEY TECHNOLOGIES     88

5.3.1.1    Portable instruments for POC diagnostic services          88

5.3.1.2    Biosensor-based diagnostic systems  89

5.3.2        ADJACENT TECHNOLOGIES       89

5.3.2.1    Wearable biosensors & remote monitoring devices        89

5.3.2.2    Development of rapid & sensitive veterinary diagnostic kits                 90

5.3.2.3    Breath & saliva-based diagnostic tools              90

5.3.2.4    Microfluidics & Lab-on-chip devices 90

5.3.3        COMPLEMENTARY TECHNOLOGIES       91

5.3.3.1    AI-driven diagnostic platforms           91

5.3.3.2    Next-generation Sequencing (NGS) 91

5.4           PORTER’S FIVE FORCES ANALYSIS           92

5.4.1        THREAT OF NEW ENTRANTS      93

5.4.2        THREAT OF SUBSTITUTES          94

5.4.3        BARGAINING POWER OF SUPPLIERS       94

5.4.4        BARGAINING POWER OF BUYERS             94

5.4.5        INTENSITY OF COMPETITIVE RIVALRY 94

5.5           REGULATORY LANDSCAPE         95

5.5.1        REGULATORY ANALYSIS               95

5.5.2        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             95

5.5.2.1    North America      95

5.5.2.2    Europe   96

5.5.2.3    Rest of the world  97

5.6           PATENT ANALYSIS          97

5.6.1        PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS   97

5.6.2        JURISDICTION & TOP APPLICANT ANALYSIS      98

5.7           TRADE ANALYSIS             100

5.7.1        TRADE DATA FOR HS CODE 9018              101

5.7.1.1    Import data for HS Code 9018           101

5.7.1.2    Export data for HS Code 9018            101

5.8           PRICING ANALYSIS          102

5.8.1        AVERAGE SELLING PRICE TREND, BY PRODUCT, 2022–2024        102

5.8.1.1    Average selling price trend of key players, by product, 2022–2024                 102

5.8.2        AVERAGE SELLING PRICE, BY REGION   103

5.8.2.1    Average selling price of clinical chemistry analyzers and blood gas & electrolyte analyzers, by region, 2024            104

5.8.2.2    Average selling price trend of clinical chemistry reagent clips & cartridges, by region, 2022–2024       104

5.8.2.3    Average selling price trend of clinical chemistry analyzers, by region, 2022–2024                 105

5.8.2.4    Average selling price trend of blood glucose strips, by region,

2022–2024              105

5.8.2.5    Average selling price trend of glucose monitors, by region,

2022–2024              105

5.8.2.6    Average selling price trend of blood gas & electrolyte reagent clips/cartridges, by region   106

5.8.2.7    Average selling price trend of blood gas & electrolyte analyzers,

by region, 2022–2024           106

5.9           REIMBURSEMENT ANALYSIS      106

5.10         KEY CONFERENCES & EVENTS, 2025–2026              107

5.11         KEY STAKEHOLDERS & BUYING CRITERIA            108

5.11.1      KEY STAKEHOLDERS IN BUYING PROCESS           108

5.11.2      BUYING CRITERIA           109

5.12         END-USER PERSPECTIVE & UNMET NEEDS          110

5.13         IMPACT OF AI ON VETERINARY DIAGNOSTICS MARKET                 110

5.13.1      INTRODUCTION              110

5.13.2      MARKET POTENTIAL IN VETERINARY DIAGNOSTICS ECOSYSTEM       110

5.13.3      AI-USE CASES    111

5.13.4      KEY COMPANIES IMPLEMENTING AI IN VETERINARY DIAGNOSTICS   111

5.14         ECOSYSTEM/MARKET MAP         112

5.15         VALUE CHAIN ANALYSIS               113

5.16         SUPPLY CHAIN ANALYSIS             114

5.17         ADJACENT MARKETS     116

5.18         INVESTMENT & FUNDING SCENARIO     116

5.19         TRUMP TARIFF IMPACT ON VETERINARY DIAGNOSTICS MARKET               117

5.19.1      INTRODUCTION              117

5.19.2      KEY TARIFF RATES          118

5.19.3      PRICE IMPACT ANALYSIS             119

5.19.4      IMPACT ON COUNTRY/REGION                120

5.19.5      IMPACT ON END-USE INDUSTRIES          122

6               VETERINARY DIAGNOSTICS MARKET, BY PRODUCT                 123

6.1           INTRODUCTION              124

6.2           CONSUMABLES 126

6.2.1        RECURRING NATURE TO BOOST DEMAND          126

6.3           INSTRUMENTS 128

6.3.1        INCREASING DEMAND FOR POC ANALYZERS TO DRIVE MARKET               128

7               VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY  130

7.1           INTRODUCTION              131

7.2           IMMUNODIAGNOSTICS                131

7.2.1        LATERAL FLOW ASSAYS                135

7.2.1.1    Lateral flow rapid tests        137

7.2.1.1.1 Ability to provide real-time insights to drive market      137

7.2.1.2    Lateral flow strip readers     139

7.2.1.2.1 Rising need for readers to determine analyte quantity to fuel adoption 139

7.2.2        ELISA    141

7.2.2.1    Cost-effectiveness and ease of use to drive market         141

7.2.3        ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS                 143

7.2.3.1    Increasing incidence of allergies in companion animals to fuel market    143

7.2.4        IMMUNOASSAY ANALYZERS       145

7.2.4.1    High sensitivity & specificity for biomarker detection to drive market    145

7.2.5        RADIOIMMUNOASSAYS 147

7.2.5.1    Measurement of hormone levels and detection of specific proteins to fuel market         147

7.2.6        OTHER IMMUNODIAGNOSTIC PRODUCTS          149

7.3           CLINICAL BIOCHEMISTRY           151

7.3.1        CLINICAL CHEMISTRY ANALYSIS              153

7.3.1.1    Clinical chemistry reagent clips & cartridges   156

7.3.1.1.1 Rising number of screening tests to fuel market              156

7.3.1.2    Clinical chemistry analyzers                157

7.3.1.2.1 Increasing installation of clinical chemistry analyzers to propel market    157

7.3.2        GLUCOSE MONITORING               160

7.3.2.1    Blood glucose strips             161

7.3.2.1.1 Growing demand in home care settings to fuel market  161

7.3.2.2    Glucose monitors 163

7.3.2.2.1 Growing incidence of diabetes in pet animals to fuel adoption                 163

7.3.2.3    Urine glucose strips              166

7.3.2.3.1 Increasing risk of DKA in animals to propel market       166

7.3.3        BLOOD GAS & ELECTROLYTE ANALYSIS               168

7.3.3.1    Blood gas & electrolyte reagent clips & cartridges          170

7.3.3.1.1 Easy availability of animal species-specific preloaded reagent clips to boost market            170

7.3.3.2    Blood gas & electrolyte analyzers       171

7.3.3.2.1 Determination of blood oxygen & carbon dioxide levels to drive market    171

7.4           MOLECULAR DIAGNOSTICS       174

7.4.1        PCR TESTS          177

7.4.1.1    Increased laboratory usage in proteomics & genomics to support growth    177

7.4.2        MICROARRAYS  179

7.4.2.1    Growing applications of biochips in identifying infectious diseases to drive market      179

7.4.3        NUCLEIC ACID SEQUENCING    181

7.4.3.1    Identification of pathogens to fuel market        181

7.4.4        OTHER MOLECULAR DIAGNOSTIC PRODUCTS 183

7.5           HEMATOLOGY 185

7.5.1        HEMATOLOGY CARTRIDGES      188

7.5.1.1    Complete blood analysis capabilities to fuel market        188

7.5.2        HEMATOLOGY ANALYZERS        189

7.5.2.1    Adoption by veterinary hospitals & clinics to support market growth    189

7.6           URINALYSIS        192

7.6.1        URINALYSIS CLIPS & CARTRIDGES/PANELS         194

7.6.1.1    Detection of electrolytes to boost adoption      194

7.6.2        URINE ANALYZERS          196

7.6.2.1    Development of advanced analyzers for POC testing to support market growth       196

7.6.3        URINE TEST STRIPS        198

7.6.3.1    Increasing prevalence of CKD in cats & dogs to drive market                 198

7.7           OTHER TECHNOLOGIES               200

8               VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE                 202

8.1           INTRODUCTION              203

8.2           COMPANION ANIMALS 203

8.2.1        DOGS    206

8.2.1.1    High insurance coverage and availability of reimbursements to drive market          206

8.2.2        CATS     208

8.2.2.1    Increasing pet cat population to support market uptake                 208

8.2.3        HORSES                210

8.2.3.1    Growing awareness regarding equine health to fuel market                 210

8.2.4        OTHER COMPANION ANIMALS 212

8.3           LIVESTOCK         214

8.3.1        CATTLE                217

8.3.1.1    Growing consumption of dairy products to drive market                 217

8.3.2        PIGS       219

8.3.2.1    Increasing incidence of infectious diseases to fuel market                 219

8.3.3        POULTRY             221

8.3.3.1    Increasing demand for poultry meat contributes to market growth                 221

8.3.4        OTHER LIVESTOCK ANIMALS    223

9               VETERINARY DIAGNOSTICS MARKET, BY APPLICATION                 225

9.1           INTRODUCTION              226

9.2           INFECTIOUS DISEASES 226

9.2.1        BACTERIAL INFECTIONS              229

9.2.1.1    Rapid spread of E. Coli to drive market            229

9.2.2        VIRAL INFECTIONS         231

9.2.2.1    High mutation rate to ensure continued demand for diagnostics                 231

9.2.3        PARASITIC INFECTIONS                233

9.2.3.1    Presence of parasitic infections to fuel market                 233

9.2.4        OTHER INFECTIONS      235

9.3           ENDOCRINOLOGY          237

9.3.1        GROWING RISK OF DIABETES TO BOOST DEMAND                 237

9.4           CARDIOLOGY    239

9.4.1        INCREASING CASES OF CVD IN DOGS TO FUEL MARKET                 239

9.5           ONCOLOGY        241

9.5.1        HIGH INCIDENCE OF CANINE CANCER TO DRIVE MARKET               241

9.6           OTHER APPLICATIONS 243

10            VETERINARY DIAGNOSTICS MARKET, BY END USER                 245

10.1         INTRODUCTION              246

10.2         VETERINARY REFERENCE LABORATORIES           246

10.2.1      LARGE VOLUME OF TESTING SAMPLES AND AVAILABILITY OF SKILLED WORKFORCE TO PROPEL MARKET                 246

10.3         VETERINARY HOSPITALS & CLINICS       248

10.3.1      GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO DRIVE MARKET             248

10.4         POINT-OF-CARE/IN-HOUSE TESTING    250

10.4.1      COST-EFFECTIVENESS AND RAPID RESULTS TO BOOST DEMAND             250

10.5         VETERINARY RESEARCH INSTITUTES & UNIVERSITIES                 252

10.5.1      INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND RESEARCH INSTITUTES TO SUPPORT GROWTH             252

11            VETERINARY DIAGNOSTICS MARKET, BY REGION                 254

11.1         INTRODUCTION              255

11.2         NORTH AMERICA             256

11.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 256

11.2.2      US           264

11.2.2.1  High veterinary healthcare expenditure to drive market                 264

11.2.3      CANADA               271

11.2.3.1  Growing pet adoption to drive market              271

11.3         EUROPE               277

11.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      278

11.3.2      GERMANY           285

11.3.2.1  Rising awareness of zoonotic diseases to fuel market     285

11.3.3      UK          292

11.3.3.1  Increasing pet ownership to drive market         292

11.3.4      FRANCE                299

11.3.4.1  Willingness of pet owners to spend on pet health to drive market                 299

11.3.5      ITALY    306

11.3.5.1  Growing consumption of meat & dairy products to drive market                 306

11.3.6      SPAIN    313

11.3.6.1  Growing demand for poultry products to fuel market    313

11.3.7      NETHERLANDS 319

11.3.7.1  Developments in veterinary diagnostic products to support market growth       319

11.3.8      REST OF EUROPE             326

11.4         ASIA PACIFIC     333

11.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 334

11.4.2      CHINA  342

11.4.2.1  Increasing incidence of zoonotic diseases to propel market                 342

11.4.3      JAPAN   349

11.4.3.1  Increasing pet expenditure to support market growth    349

11.4.4      INDIA    357

11.4.4.1  Increasing demand for dairy products to drive market   357

11.4.5      AUSTRALIA         365

11.4.5.1  Rise in pet ownership to support market growth             365

11.4.6      SOUTH KOREA  372

11.4.6.1  Rising need for specialized veterinary services to drive market                 372

11.4.7      NEW ZEALAND 379

11.4.7.1  Focus on pet insurance to aid market                379

11.4.8      VIETNAM             386

11.4.8.1  Growing focus on disease surveillance to drive market  386

11.4.9      REST OF ASIA PACIFIC   393

11.5         LATIN AMERICA                399

11.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 400

11.5.2      BRAZIL 407

11.5.2.1  Growth in livestock industry to boost demand                 407

11.5.3      MEXICO                414

11.5.3.1  Increasing focus on poultry-associated products to support market growth       414

11.5.4      REST OF LATIN AMERICA             421

11.6         MIDDLE EAST & AFRICA                428

11.6.1      MACROECONOMIC OUTLOOK FOR THE MIDDLE EAST & AFRICA             429

11.6.2      GCC COUNTRIES              436

11.6.2.1  Kingdom of Saudi Arabia (KSA)        443

11.6.2.1.1                Technology advancements in veterinary diagnostics to boost demand        443

11.6.2.2  United Arab Emirates (UAE)             450

11.6.2.2.1                Favorable government support for vet diagnostics to drive market          450

11.6.2.3  Other GCC Countries          457

11.6.3      REST OF MIDDLE EAST & AFRICA             464

12            COMPETITIVE LANDSCAPE         472

12.1         OVERVIEW          472

12.2         KEY PLAYER STRATEGY/RIGHT TO WIN                472

12.3         REVENUE ANALYSIS, 2020–2024  474

12.4         MARKET SHARE ANALYSIS           474

12.4.1      RANKING OF KEY MARKET PLAYERS       476

12.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 477

12.5.1      STARS   477

12.5.2      EMERGING LEADERS     478

12.5.3      PERVASIVE PLAYERS      478

12.5.4      PARTICIPANTS 478

12.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         479

12.5.5.1  Company footprint               479

12.5.5.2  Region footprint   480

12.5.5.3  Product footprint  481

12.5.5.4  Technology footprint           482

12.5.5.5  Animal type footprint           483

12.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        484

12.6.1      PROGRESSIVE COMPANIES         484

12.6.2      RESPONSIVE COMPANIES            484

12.6.3      DYNAMIC COMPANIES  484

12.6.4      STARTING BLOCKS         484

12.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 486

12.6.5.1  Detailed list of key startups/SMEs    486

12.6.5.2  Competitive benchmarking of key startups      487

12.7         BRAND/PRODUCT COMPARATIVE ANALYSIS     488

12.8         R&D EXPENDITURE OF KEY PLAYERS     489

12.9         COMPANY VALUATION & FINANCIAL METRICS 489

12.9.1      FINANCIAL METRICS      489

12.9.2      COMPANY VALUATION 490

12.10       COMPETITIVE SCENARIO             490

12.10.1   PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS        490

12.10.2   DEALS  492

12.10.3   EXPANSIONS     492

12.10.4   OTHER DEVELOPMENTS              493

13            COMPANY PROFILES      494

13.1         KEY PLAYERS     494

13.1.1      IDEXX LABORATORIES, INC.       494

13.1.1.1  Business overview 494

13.1.1.2  Products/Services offered   495

13.1.1.3  Recent developments           500

13.1.1.3.1                Product/Service launches, enhancements, and approvals                500

13.1.1.4  MnM view              501

13.1.1.4.1                Key strengths        501

13.1.1.4.2                Strategic choices   501

13.1.1.4.3                Weaknesses & competitive threats     502

13.1.2      ZOETIS SERVICES LLC    503

13.1.2.1  Business overview 503

13.1.2.2  Products/Services offered   504

13.1.2.3  Recent developments           506

13.1.2.3.1                Product/Service launches, enhancements, and approvals                506

13.1.2.3.2                Deals      507

13.1.2.3.3                Expansions             507

13.1.2.4  MnM view              507

13.1.2.4.1                Key strengths        507

13.1.2.4.2                Strategic choices   508

13.1.2.4.3                Weaknesses & competitive threats     508

13.1.3      THERMO FISHER SCIENTIFIC INC.            509

13.1.3.1  Business overview 509

13.1.3.2  Products/Services offered   510

13.1.3.3  MnM view              517

13.1.3.3.1                Key strengths        517

13.1.3.3.2                Strategic choices   517

13.1.3.3.3                Weaknesses & competitive threats     517

13.1.4      ANTECH DIAGNOSTICS, INC.     518

13.1.4.1  Business overview 518

13.1.4.2  Products/Services offered   518

13.1.4.3  Recent developments           519

13.1.4.3.1                Product/Service launches, enhancements, and approvals                519

13.1.4.3.2                Expansions             520

13.1.4.4  MnM view              520

13.1.4.4.1                Key strengths        520

13.1.4.4.2                Strategic choices   520

13.1.4.4.3                Weaknesses & competitive threats     520

13.1.5      BIOMÉRIEUX     521

13.1.5.1  Business overview 521

13.1.5.2  Products/Services offered   522

13.1.5.3  Recent developments           523

13.1.5.3.1                Product/Service launches, enhancements, and approvals                523

13.1.5.4  MnM view              523

13.1.5.4.1                Key strengths        523

13.1.5.4.2                Strategic choices   523

13.1.5.4.3                Weaknesses & competitive threats     524

13.1.6      NEOGEN CORPORATION              525

13.1.6.1  Business overview 525

13.1.6.2  Products/Services offered   526

13.1.6.3  Recent developments           528

13.1.6.3.1                Product/Service launches, enhancements, and approvals                528

13.1.6.3.2                Deals      529

13.1.6.3.3                Other developments             529

13.1.7      BIO-RAD LABORATORIES, INC.  530

13.1.7.1  Business overview 530

13.1.7.2  Products/Services offered   531

13.1.8      VIRBAC 533

13.1.8.1  Business overview 533

13.1.8.2  Products/Services offered   534

13.1.8.3  Recent developments           535

13.1.8.3.1                Deals      535

13.1.8.3.2                Expansions             536

13.1.9      FUJIFILM HOLDINGS CORPORATION     537

13.1.9.1  Business overview 537

13.1.9.2  Products/Services offered   538

13.1.10   SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.             539

13.1.10.1                 Business overview 539

13.1.10.2                 Products/Services offered   540

13.1.10.3                 Recent developments           541

13.1.10.3.1             Product/Service launches, enhancements, and approvals                541

13.1.10.3.2             Expansions             541

13.1.11   INDICAL BIOSCIENCE GMBH      542

13.1.11.1                 Business overview 542

13.1.11.2                 Products/Services offered   542

13.1.11.3                 Recent developments           545

13.1.11.3.1             Product/Service launches, enhancements, and approvals                545

13.1.12   BIONOTE             546

13.1.12.1                 Business overview 546

13.1.12.2                 Products/Services offered   546

13.1.12.3                 Recent developments           549

13.1.12.4                 Product/Service launches, enhancements, and approvals                549

13.1.12.4.1             Deals      550

13.1.13   BIOGAL                551

13.1.13.1                 Business overview 551

13.1.13.2                 Products/Services offered   551

13.1.14   AGROLABO S.P.A.             553

13.1.14.1                 Business overview 553

13.1.14.2                 Products/Services offered   553

13.1.15   INNOVATIVE DIAGNOSTICS       558

13.1.15.1                 Business overview 558

13.1.15.2                 Products/Services offered   558

13.2         OTHER PLAYERS              566

13.2.1      RANDOX LABORATORIES LTD. 566

13.2.2      BIOCHEK             567

13.2.3      FASSISI, GMBH  568

13.2.4      ALVEDIA              569

13.2.5      SKYER, INC.        570

13.2.6      SHENZHEN BIOEASY BIOTECHNOLOGY, INC.     571

13.2.7      PRECISION BIOSENSOR, INC.      572

13.2.8      EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG                 573

13.2.9      GOLD STANDARD DIAGNOSTICS             574

13.2.10   SKYLA CORPORATION  575

14            APPENDIX           576

14.1         DISCUSSION GUIDE        576

14.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                581

14.3         RELATED REPORTS         583

14.4         AUTHOR DETAILS           584

LIST OF TABLES

TABLE 1                STANDARD CURRENCY CONVERSION RATES (USD)    48

TABLE 2                VETERINARY DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS             64

TABLE 3                VETERINARY DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS 65

TABLE 4                NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024, BY ANIMAL TYPE (MILLIONS)           76

TABLE 5                ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2023)                 79

TABLE 6                AVERAGE PREMIUMS PAID IN US, 2020 VS. 2023                 81

TABLE 7                NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2023) (USD MILLION)      82

TABLE 8                VETERINARY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS           93

TABLE 9                NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 95

TABLE 10              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           96

TABLE 11              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 97

TABLE 12              VETERINARY DIAGNOSTICS MARKET: MAJOR PATENTS             99

TABLE 13             IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020–2023 (USD THOUSANDS)    101

TABLE 14              EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2023 (USD THOUSANDS)             101

TABLE 15              AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024            102

TABLE 16              AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES, BY REGION, 2022–2024        104

TABLE 17              AVERAGE SELLING PRICE TREND FOR CLINICAL CHEMISTRY ANALYZERS,

BY REGION, 2022–2024    105

TABLE 18              AVERAGE SELLING PRICE TREND OF BLOOD GLUCOSE STRIPS, BY REGION,

2022–2024              105

TABLE 19              AVERAGE SELLING PRICE TREND OF GLUCOSE MONITORS, BY REGION,

2022–2024              105

TABLE 20              AVERAGE SELLING PRICE TREND OF BLOOD GAS & ELECTROLYTE REAGENT CLIPS/CARTRIDGES, BY REGION, 2022–2024           106

TABLE 21              AVERAGE SELLING PRICE TREND OF BLOOD GAS & ELECTROLYTE ANALYZERS,

BY REGION, 2022–2024    106

TABLE 22              VETERINARY DIAGNOSTICS MARKET: KEY CONFERENCES & EVENTS, 2025–2026       107

TABLE 23              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTIC PRODUCTS (%)                 108

TABLE 24              KEY COMPANIES IMPLEMENTING AI IN VETERINARY DIAGNOSTICS       112

TABLE 25              VETERINARY DIAGNOSTIC PROVIDERS: ROLE OF COMPANIES IN ECOSYSTEM 113

TABLE 26              US-ADJUSTED RECIPROCAL TARIFF RATES                 118

TABLE 27              KEY PRODUCT-RELATED TARIFFS FOR VETERINARY DIAGNOSTICS       119

TABLE 28              NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS         120

TABLE 29              ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS          120

TABLE 30              EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 121

TABLE 31              LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS         122

TABLE 32              VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     124

TABLE 33              VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     125

TABLE 34              KEY PLAYERS OFFERING VETERINARY DIAGNOSTIC CONSUMABLES    126

TABLE 35              VETERINARY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            127

TABLE 36              KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC INSTRUMENTS      128

TABLE 37              VETERINARY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            129

TABLE 38              VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            131

TABLE 39              KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES                132

TABLE 40              VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            133

TABLE 41              VETERINARY IMMUNODIAGNOSTICS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            134

TABLE 42              KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS 135

TABLE 43              LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)            135

TABLE 44              LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            136

TABLE 45              KEY PLAYERS PROVIDING LATERAL FLOW RAPID TESTS     137

TABLE 46              LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     138

TABLE 47              KEY PLAYERS PROVIDING LATERAL FLOW STRIP READERS                 139

TABLE 48              LATERAL FLOW STRIP READERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            140

TABLE 49              KEY PLAYERS PROVIDING ELISA TESTS 141

TABLE 50              ELISA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            142

TABLE 51              KEY PLAYERS PROVIDING ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS    143

TABLE 52              ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            144

TABLE 53              KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS        145

TABLE 54              IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     146

TABLE 55              KEY PLAYERS PROVIDING RADIOIMMUNOASSAYS 147

TABLE 56              RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            148

TABLE 57              KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC PRODUCTS          149

TABLE 58              OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            150

TABLE 59              KEY PLAYERS PROVIDING CLINICAL BIOCHEMISTRY PRODUCTS        151

TABLE 60              VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            152

TABLE 61              VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            153

TABLE 62              KEY PLAYERS PROVIDING CLINICAL CHEMISTRY ANALYSIS  154

TABLE 63              CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                154

TABLE 64              CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            155

TABLE 65              KEY PLAYERS PROVIDING CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES      156

TABLE 66              CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 157

TABLE 67              KEY PLAYERS PROVIDING CLINICAL CHEMISTRY ANALYZERS               158

TABLE 68              CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION,

2023–2030 (THOUSAND UNITS)  158

TABLE 69              CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            159

TABLE 70              KEY PLAYERS PROVIDING GLUCOSE MONITORING   160

TABLE 71              GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)            160

TABLE 72              GLUCOSE MONITORING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     161

TABLE 73              KEY PLAYERS PROVIDING BLOOD GLUCOSE STRIPS  162

TABLE 74              BLOOD GLUCOSE STRIPS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)  162

TABLE 75              BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     163

TABLE 76              KEY PLAYERS PROVIDING GLUCOSE MONITORS                 164

TABLE 77              GLUCOSE MONITORS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)  164

TABLE 78              GLUCOSE MONITORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            165

TABLE 79              KEY PLAYERS PROVIDING URINE GLUCOSE STRIPS  166

TABLE 80             URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            167

TABLE 81              KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE ANALYSIS             168

TABLE 82              BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            168

TABLE 83              BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            169

TABLE 84              KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES                170

TABLE 85              BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               171

TABLE 86              KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE ANALYZERS         172

TABLE 87              BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY REGION,

2023–2030 (THOUSAND UNITS)                172

TABLE 88              BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            173

TABLE 89              KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS   174

TABLE 90              VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            175

TABLE 91              VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            176

TABLE 92              KEY PLAYERS PROVIDING PCR TESTS    177

TABLE 93              PCR TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 178

TABLE 94              KEY PLAYERS PROVIDING MICROARRAYS                 179

TABLE 95              MICROARRAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       180

TABLE 96              KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING    181

TABLE 97              NUCLEIC ACID SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     182

TABLE 98              KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC PRODUCTS             183

TABLE 99              OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            184

TABLE 100            KEY PLAYERS PROVIDING HEMATOLOGY PRODUCTS         185

TABLE 101            VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)            186

TABLE 102            VETERINARY HEMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     187

TABLE 103            KEY PLAYERS PROVIDING HEMATOLOGY CARTRIDGES     188

TABLE 104            HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     189

TABLE 105            KEY PLAYERS PROVIDING HEMATOLOGY ANALYZERS        190

TABLE 106            HEMATOLOGY ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)                190

TABLE 107            HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     191

TABLE 108            KEY PLAYERS PROVIDING URINALYSIS PRODUCTS         192

TABLE 109            VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)            192

TABLE 110            VETERINARY URINALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     193

TABLE 111            KEY PLAYERS PROVIDING URINALYSIS CLIPS & CARTRIDGES     194

TABLE 112            URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            195

TABLE 113            KEY PLAYERS PROVIDING URINE ANALYZERS                 196

TABLE 114            URINE ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)             196

TABLE 115            URINE ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            197

TABLE 116            KEY PLAYERS PROVIDING URINE TEST STRIPS                 198

TABLE 117            URINE TEST STRIPS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)             198

TABLE 118            URINE TEST STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            199

TABLE 119            KEY PLAYERS PROVIDING OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES  200

TABLE 120            OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            201

TABLE 121            VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              203

TABLE 122            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR COMPANION ANIMALS          203

TABLE 123            VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE,

2023–2030 (USD MILLION)            204

TABLE 124            VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)                 205

TABLE 125            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR DOGS            206

TABLE 126            VETERINARY DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY,

2023–2030 (USD MILLION)            207

TABLE 127            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CATS              208

TABLE 128            VETERINARY DIAGNOSTICS MARKET FOR CATS, BY COUNTRY,

2023–2030 (USD MILLION)            209

TABLE 129            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR HORSES        210

TABLE 130            VETERINARY DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY,

2023–2030 (USD MILLION)            211

TABLE 131            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER COMPANION ANIMALS          212

TABLE 132            VETERINARY DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS,

BY COUNTRY, 2023–2030 (USD MILLION)               213

TABLE 133            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR LIVESTOCK 214

TABLE 134            VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            215

TABLE 135            VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY,

2023–2030 (USD MILLION)            216

TABLE 136            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CATTLE        217

TABLE 137            VETERINARY DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY,

2023–2030 (USD MILLION)            218

TABLE 138            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR PIGS               219

TABLE 139            VETERINARY DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY,

2023–2030 (USD MILLION)            220

TABLE 140            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR POULTRY    221

TABLE 141            VETERINARY DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY,

2023–2030 (USD MILLION)            222

TABLE 142            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER LIVESTOCK ANIMALS             223

TABLE 143            VETERINARY DIAGNOSTICS MARKET FOR OTHER LIVESTOCK ANIMALS,

BY COUNTRY, 2023–2030 (USD MILLION)               224

TABLE 144            VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              226

TABLE 145            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR INFECTIOUS DISEASES          227

TABLE 146            VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)                 227

TABLE 147            VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)                 228

TABLE 148            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR BACTERIAL INFECTIONS      229

TABLE 149            VETERINARY DIAGNOSTICS MARKET FOR BACTERIAL INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)            230

TABLE 150            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR VIRAL INFECTIONS 231

TABLE 151            VETERINARY DIAGNOSTICS MARKET FOR VIRAL INFECTIONS, BY COUNTRY,

2023–2030 (USD MILLION)            232

TABLE 152            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR PARASITIC INFECTIONS       233

TABLE 153            VETERINARY DIAGNOSTICS MARKET FOR PARASITIC INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)            234

TABLE 154            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER INFECTIONS               235

TABLE 155            VETERINARY DIAGNOSTICS MARKET FOR OTHER INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)                 236

TABLE 156            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR ENDOCRINOLOGY APPLICATIONS  237

TABLE 157            VETERINARY DIAGNOSTICS MARKET FOR ENDOCRINOLOGY, BY COUNTRY,

2023–2030 (USD MILLION)            238

TABLE 158            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CARDIOLOGY APPLICATIONS            239

TABLE 159            VETERINARY DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY,

2023–2030 (USD MILLION)            240

TABLE 160            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR ONCOLOGY APPLICATIONS                241

TABLE 161            VETERINARY DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY,

2023–2030 (USD MILLION)            242

TABLE 162            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER APPLICATIONS         243

TABLE 163            VETERINARY DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            244

TABLE 164            VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)                246

TABLE 165            VETERINARY DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)       247

TABLE 166            BASIC ANNUAL EXPENSES FOR CATS & DOGS IN US (2023) (USD) 248

TABLE 167            VETERINARY DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS,

BY COUNTRY, 2023–2030 (USD MILLION)               249

TABLE 168            VETERINARY DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)            251

TABLE 169            VETERINARY DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023–2030 (USD MILLION)     253

TABLE 170            VETERINARY DIAGNOSTICS MARKET, BY REGION, 2023–2030 (USD MILLION)          255

TABLE 171            NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            258

TABLE 172            NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            258

TABLE 173            NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            258

TABLE 174            NORTH AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            259

TABLE 175            NORTH AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            259

TABLE 176            NORTH AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            260

TABLE 177            NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            260

TABLE 178            NORTH AMERICA: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            260

TABLE 179            NORTH AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 261

TABLE 180            NORTH AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 261

TABLE 181            NORTH AMERICA: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            261

TABLE 182            NORTH AMERICA: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            262

TABLE 183            NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            262

TABLE 184            NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            262

TABLE 185            NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)                 263

TABLE 186            NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            263

TABLE 187            NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)            263

TABLE 188            NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            264

TABLE 189            US: KEY MACRO INDICATORS    265

TABLE 190            US: VETERINARY DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)                265

TABLE 191            US: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            265

TABLE 192            US: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            266

TABLE 193            US: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            266

TABLE 194            US: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            266

TABLE 195            US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            267

TABLE 196            US: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)            267

TABLE 197            US: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            267

TABLE 198            US: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            268

TABLE 199            US: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)                268

TABLE 200          US: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)            268

TABLE 201            US: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            269

TABLE 202            US: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 269

TABLE 203            US: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            269

TABLE 204            US: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            270

TABLE 205            US: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)                 270

TABLE 206            US: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            270

TABLE 207            CANADA: KEY MACRO INDICATORS        271

TABLE 208            CANADA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            271

TABLE 209            CANADA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            272

TABLE 210            CANADA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            272

TABLE 211            CANADA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            273

TABLE 212            CANADA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            273

TABLE 213            CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            273

TABLE 214            CANADA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)                274

TABLE 215            CANADA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            274

TABLE 216            CANADA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            274

TABLE 217          CANADA: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            275

TABLE 218            CANADA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)         275

TABLE 219            CANADA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            275

TABLE 220            CANADA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,

BY TYPE, 2023–2030 (USD MILLION)         276

TABLE 221            CANADA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            276

TABLE 222            CANADA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            276

TABLE 223            CANADA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,

BY TYPE, 2023–2030 (USD MILLION)         277

TABLE 224            CANADA: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            277

TABLE 225            EUROPE: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            279

TABLE 226            EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            279

TABLE 227            EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            279

TABLE 228            EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            280

TABLE 229            EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            280

TABLE 230            EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            281

TABLE 231            EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            281

TABLE 232            EUROPE: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)                281

TABLE 233            EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            282

TABLE 234            EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            282

TABLE 235            EUROPE: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            282

TABLE 236            EUROPE: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                283

TABLE 237            EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            283

TABLE 238            EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,

BY TYPE, 2023–2030 (USD MILLION)         283

TABLE 239            EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            284

TABLE 240            EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            284

TABLE 241            EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,

BY TYPE, 2023–2030 (USD MILLION)         284

TABLE 242            EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            285

TABLE 243            GERMANY: KEY MACRO INDICATORS    286

TABLE 244            GERMANY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            286

TABLE 245            GERMANY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            286

TABLE 246            GERMANY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            287

TABLE 247            GERMANY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            287

TABLE 248            GERMANY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            288

TABLE 249            GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            288

TABLE 250            GERMANY: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)         288

TABLE 251            GERMANY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            289

TABLE 252            GERMANY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            289

TABLE 253            GERMANY: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            289

TABLE 254            GERMANY: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            290

TABLE 255            GERMANY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            290

TABLE 256            GERMANY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,

BY TYPE, 2023–2030 (USD MILLION)         290

TABLE 257            GERMANY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            291

TABLE 258            GERMANY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            291

TABLE 259            GERMANY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,

BY TYPE, 2023–2030 (USD MILLION)         291

TABLE 260            GERMANY: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            292

TABLE 261            UK: KEY MACRO INDICATORS   293

TABLE 262            UK: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            293

TABLE 263            UK: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            294

TABLE 264            UK: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            294

TABLE 265            UK: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            295

TABLE 266            UK: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            295

TABLE 267            UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)          295

TABLE 268            UK: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)            296

TABLE 269            UK: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            296

TABLE 270            UK: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            296

TABLE 271            UK: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)                297

TABLE 272          UK: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)            297

TABLE 273            UK: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            297

TABLE 274            UK: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 298

TABLE 275            UK: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            298

TABLE 276            UK: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            298

TABLE 277            UK: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)                 299

TABLE 278            UK: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            299

TABLE 279            FRANCE: KEY MACRO INDICATORS         300

TABLE 280            FRANCE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            300

TABLE 281            FRANCE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            300

TABLE 282            FRANCE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            301

TABLE 283            FRANCE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            301

TABLE 284            FRANCE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            302

TABLE 285            FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            302

TABLE 286            FRANCE: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)                302

TABLE 287            FRANCE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            303

TABLE 288            FRANCE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            303

TABLE 289            FRANCE: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            303

TABLE 290            FRANCE: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                304

TABLE 291            FRANCE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            304

TABLE 292            FRANCE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 304

TABLE 293            FRANCE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            305

TABLE 294            FRANCE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            305

TABLE 295            FRANCE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,

BY TYPE, 2023–2030 (USD MILLION)         306

TABLE 296            FRANCE: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            306

TABLE 297            ITALY: KEY MACRO INDICATORS              307

TABLE 298            ITALY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            307

TABLE 299            ITALY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            307

TABLE 300            ITALY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            308

TABLE 301            ITALY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            308

TABLE 302            ITALY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            308

TABLE 303            ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            309

TABLE 304            ITALY: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)                309

TABLE 305            ITALY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            309

TABLE 306            ITALY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            310

TABLE 307            ITALY: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)         310

TABLE 308            ITALY: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                310

TABLE 309            ITALY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            311

TABLE 310            ITALY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 311

TABLE 311            ITALY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            311

TABLE 312            ITALY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            312

TABLE 313            ITALY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)                 312

TABLE 314            ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            312

TABLE 315            SPAIN: KEY MACRO INDICATORS              313

TABLE 316            SPAIN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)          313

TABLE 317            SPAIN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            314

TABLE 318            SPAIN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            314

TABLE 319            SPAIN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            315

TABLE 320            SPAIN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            315

TABLE 321            SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            315

TABLE 322            SPAIN: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)                316

TABLE 323            SPAIN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            316

TABLE 324            SPAIN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            316

TABLE 325            SPAIN: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)         317

TABLE 326            SPAIN: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                317

TABLE 327            SPAIN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            317

TABLE 328            SPAIN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 318

TABLE 329            SPAIN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            318

TABLE 330            SPAIN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            318

TABLE 331            SPAIN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)                 319

TABLE 332            SPAIN: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            319

TABLE 333            NETHERLANDS: KEY MACRO INDICATORS                 320

TABLE 334            NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            320

TABLE 335            NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            321

TABLE 336            NETHERLANDS: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            321

TABLE 337            NETHERLANDS: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            322

TABLE 338            NETHERLANDS: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            322

TABLE 339            NETHERLANDS: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            322

TABLE 340            NETHERLANDS: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            323

TABLE 341            NETHERLANDS: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            323

TABLE 342            NETHERLANDS: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 323

TABLE 343            NETHERLANDS: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            324

TABLE 344            NETHERLANDS: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            324

TABLE 345            NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            324

TABLE 346            NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            325

TABLE 347            NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)                 325

TABLE 348            NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            325

TABLE 349            NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)            326

TABLE 350            NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            326

TABLE 351            REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            327

TABLE 352            REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            327

TABLE 353            REST OF EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            328

TABLE 354            REST OF EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            328

TABLE 355            REST OF EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)                 328

TABLE 356            REST OF EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            329

TABLE 357            REST OF EUROPE: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            329

TABLE 358            REST OF EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 329

TABLE 359            REST OF EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 330

TABLE 360            REST OF EUROPE: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            330

TABLE 361            REST OF EUROPE: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            330

TABLE 362            REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            331

TABLE 363            REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            331

TABLE 364            REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)                 331

TABLE 365            REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            332

TABLE 366            REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)            332

TABLE 367            REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            333

TABLE 368            ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            336

TABLE 369            ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            336

TABLE 370            ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            337

TABLE 371            ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            337

TABLE 372            ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            338

TABLE 373            ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            338

TABLE 374            ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            338

TABLE 375          ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            339

TABLE 376            ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            339

TABLE 377            ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            339

TABLE 378            ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            340

TABLE 379            ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            340

TABLE 380            ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            340

TABLE 381            ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,

BY TYPE, 2023–2030 (USD MILLION)         341

TABLE 382            ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)                 341

TABLE 383            ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            341

TABLE 384            ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,

BY TYPE, 2023–2030 (USD MILLION)         342

TABLE 385            ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            342

TABLE 386            CHINA: KEY MACRO INDICATORS            343

TABLE 387            CHINA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)          343

TABLE 388            CHINA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            344

TABLE 389            CHINA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            344

TABLE 390            CHINA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            345

TABLE 391            CHINA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            345

TABLE 392            CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            345

TABLE 393            CHINA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)                346

TABLE 394            CHINA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            346

TABLE 395            CHINA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            346

TABLE 396            CHINA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)         347

TABLE 397            CHINA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                347

TABLE 398            CHINA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            347

TABLE 399            CHINA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 348

TABLE 400            CHINA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            348

TABLE 401            CHINA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            348

TABLE 402            CHINA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)                 349

TABLE 403            CHINA: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            349

TABLE 404            JAPAN: KEY MACRO INDICATORS             350

TABLE 405            JAPAN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            351

TABLE 406            JAPAN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            351

TABLE 407            JAPAN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            352

TABLE 408            JAPAN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            352

TABLE 409            JAPAN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            352

TABLE 410            JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            353

TABLE 411            JAPAN: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)                353

TABLE 412            JAPAN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            353

TABLE 413            JAPAN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            354

TABLE 414            JAPAN: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)         354

TABLE 415            JAPAN: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                354

TABLE 416            JAPAN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            355

TABLE 417            JAPAN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 355

TABLE 418            JAPAN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            355

TABLE 419            JAPAN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            356

TABLE 420            JAPAN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)                 356

TABLE 421            JAPAN: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            357

TABLE 422            INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 358

TABLE 423            INDIA: KEY MACRO INDICATORS              358

TABLE 424            INDIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            359

TABLE 425            INDIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            359

TABLE 426            INDIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            360

TABLE 427            INDIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            360

TABLE 428            INDIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            360

TABLE 429            INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            361

TABLE 430            INDIA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)                361

TABLE 431            INDIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            361

TABLE 432            INDIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            362

TABLE 433            INDIA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)         362

TABLE 434            INDIA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                362

TABLE 435            INDIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            363

TABLE 436            INDIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 363

TABLE 437            INDIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            363

TABLE 438            INDIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            364

TABLE 439            INDIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)                 364

TABLE 440            INDIA: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            365

TABLE 441            AUSTRALIA: KEY MACRO INDICATORS  365

TABLE 442            AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            366

TABLE 443            AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            366

TABLE 444            AUSTRALIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            367

TABLE 445            AUSTRALIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            367

TABLE 446            AUSTRALIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            368

TABLE 447            AUSTRALIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            368

TABLE 448            AUSTRALIA: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            368

TABLE 449            AUSTRALIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            369

TABLE 450            AUSTRALIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)          369

TABLE 451            AUSTRALIA: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            369

TABLE 452            AUSTRALIA: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)          370

TABLE 453            AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            370

TABLE 454            AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,

BY TYPE, 2023–2030 (USD MILLION)         370

TABLE 455            AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            371

TABLE 456            AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            371

TABLE 457            AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,

BY TYPE, 2023–2030 (USD MILLION)         371

TABLE 458            AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            372

TABLE 459            SOUTH KOREA: KEY MACRO INDICATORS                 372

TABLE 460            SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            373

TABLE 461            SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            373

TABLE 462            SOUTH KOREA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            374

TABLE 463            SOUTH KOREA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            374

TABLE 464            SOUTH KOREA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            374

TABLE 465            SOUTH KOREA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            375

TABLE 466            SOUTH KOREA: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            375

TABLE 467            SOUTH KOREA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            375

TABLE 468            SOUTH KOREA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            376

TABLE 469            SOUTH KOREA: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            376

TABLE 470            SOUTH KOREA: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            376

TABLE 471            SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            377

TABLE 472            SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            377

TABLE 473            SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)                 377

TABLE 474            SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            378

TABLE 475            SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)            378

TABLE 476            SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            379

TABLE 477            NEW ZEALAND: KEY MACRO INDICATORS                 379

TABLE 478            NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            380

TABLE 479            NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            380

TABLE 480            NEW ZEALAND: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            381

TABLE 481            NEW ZEALAND: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            381

TABLE 482            NEW ZEALAND: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            381

TABLE 483            NEW ZEALAND: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)          382

TABLE 484            NEW ZEALAND: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            382

TABLE 485            NEW ZEALAND: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            382

TABLE 486            NEW ZEALAND: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            383

TABLE 487            NEW ZEALAND: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            383

TABLE 488            NEW ZEALAND: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            383

TABLE 489            NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)   384

TABLE 490            NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            384

TABLE 491            NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)                 384

TABLE 492            NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            385

TABLE 493            NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)            385

TABLE 494            NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            386

TABLE 495            VIETNAM: KEY MACRO INDICATORS      386

TABLE 496          VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            387

TABLE 497          VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            387

TABLE 498            VIETNAM: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            388

TABLE 499            VIETNAM: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            388

TABLE 500            VIETNAM: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            388

TABLE 501            VIETNAM: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            389

TABLE 502            VIETNAM: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)                389

TABLE 503            VIETNAM: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            389

TABLE 504            VIETNAM: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            390

TABLE 505            VIETNAM: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            390

TABLE 506            VIETNAM: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)         390

TABLE 507          VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            391

TABLE 508            VIETNAM: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,

BY TYPE, 2023–2030 (USD MILLION)         391

TABLE 509            VIETNAM: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            391

TABLE 510          VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            392

TABLE 511            VIETNAM: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,

BY TYPE, 2023–2030 (USD MILLION)         392

TABLE 512          VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            393

TABLE 513            REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            393

TABLE 514            REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            394

TABLE 515            REST OF ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)            394

TABLE 516            REST OF ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 395

TABLE 517            REST OF ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)                 395

TABLE 518            REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            395

TABLE 519            REST OF ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            396

TABLE 520            REST OF ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)            396

TABLE 521            REST OF ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)            396

TABLE 522            REST OF ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            397

TABLE 523            REST OF ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            397

TABLE 524            REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            397

TABLE 525            REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            398

TABLE 526            REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,

BY TYPE, 2023–2030 (USD MILLION)         398

TABLE 527            REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            398

TABLE 528            REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)            399

TABLE 529            REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            399

TABLE 530            LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            400

TABLE 531            LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            401

TABLE 532            LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            401

TABLE 533            LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            402

TABLE 534            LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            402

TABLE 535            LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            402

TABLE 536            LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            403

TABLE 537            LATIN AMERICA: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            403

TABLE 538            LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            403

TABLE 539            LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 404

TABLE 540            LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            404

TABLE 541            LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            404

TABLE 542            LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            405

TABLE 543            LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            405

TABLE 544            LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)                 405

TABLE 545            LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            406

TABLE 546            LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)            406

TABLE 547            LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            407

TABLE 548            BRAZIL: KEY MACRO INDICATORS           408

TABLE 549            BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            408

TABLE 550            BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            408

TABLE 551            BRAZIL: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            409

TABLE 552            BRAZIL: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            409

TABLE 553            BRAZIL: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            409

TABLE 554            BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            410

TABLE 555            BRAZIL: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)                410

TABLE 556            BRAZIL: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            410

TABLE 557            BRAZIL: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            411

TABLE 558            BRAZIL: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            411

TABLE 559            BRAZIL: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                411

TABLE 560            BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            412

TABLE 561            BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 412

TABLE 562            BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            412

TABLE 563            BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            413

TABLE 564            BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)                 413

TABLE 565            BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            413

TABLE 566            MEXICO: KEY MACRO INDICATORS         414

TABLE 567            MEXICO: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            414

TABLE 568            MEXICO: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030(USD MILLION)              415

TABLE 569            MEXICO: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            415

TABLE 570            MEXICO: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            416

TABLE 571            MEXICO: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            416

TABLE 572            MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            416

TABLE 573            MEXICO: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)                417

TABLE 574            MEXICO: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            417

TABLE 575            MEXICO: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            417

TABLE 576            MEXICO: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            418

TABLE 577            MEXICO: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                418

TABLE 578            MEXICO: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            418

TABLE 579            MEXICO: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 419

TABLE 580            MEXICO: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,

2023–2030 (USD MILLION)            419

TABLE 581            MEXICO: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            420

TABLE 582            MEXICO: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,

BY TYPE, 2023–2030 (USD MILLION)         420

TABLE 583            MEXICO: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            421

TABLE 584            REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            421

TABLE 585            REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            422

TABLE 586            REST OF LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)            422

TABLE 587            REST OF LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)            423

TABLE 588            REST OF LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET,

BY TYPE, 2023–2030 (USD MILLION)         423

TABLE 589            REST OF LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)            423

TABLE 590            REST OF LATIN AMERICA: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            424

TABLE 591            REST OF LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         424

TABLE 592            REST OF LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         424

TABLE 593            REST OF LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            425

TABLE 594            REST OF LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            425

TABLE 595            REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            425

TABLE 596            REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            426

TABLE 597            REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,

BY TYPE, 2023–2030 (USD MILLION)         426

TABLE 598            REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            427

TABLE 599            REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)            427

TABLE 600            REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            428

TABLE 601            MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY REGION,

2023–2030 (USD MILLION)            429

TABLE 602            MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            430

TABLE 603            MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            430

TABLE 604            MIDDLE EAST & AFRICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)            431

TABLE 605            MIDDLE EAST & AFRICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 431

TABLE 606            MIDDLE EAST & AFRICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)            432

TABLE 607            MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 432

TABLE 608            MIDDLE EAST & AFRICA: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            432

TABLE 609            MIDDLE EAST & AFRICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)            433

TABLE 610            MIDDLE EAST & AFRICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         433

TABLE 611            MIDDLE EAST & AFRICA: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            433

TABLE 612            MIDDLE EAST & AFRICA: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            434

TABLE 613            MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            434

TABLE 614            MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            434

TABLE 615            MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,

BY TYPE, 2023–2030 (USD MILLION)         435

TABLE 616            MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            435

TABLE 617            MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)            436

TABLE 618            MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            436

TABLE 619            GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            437

TABLE 620            GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            437

TABLE 621            GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            438

TABLE 622            GCC COUNTRIES: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            438

TABLE 623            GCC COUNTRIES: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,

2023–2030 (USD MILLION)            439

TABLE 624            GCC COUNTRIES: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,

2023–2030 (USD MILLION)            439

TABLE 625            GCC COUNTRIES: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            439

TABLE 626            GCC COUNTRIES: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            440

TABLE 627            GCC COUNTRIES: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 440

TABLE 628            GCC COUNTRIES: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 440

TABLE 629            GCC COUNTRIES: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            441

TABLE 630            GCC COUNTRIES: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            441

TABLE 631            GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            441

TABLE 632            GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            442

TABLE 633            GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)                 442

TABLE 634            GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            442

TABLE 635            GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)            443

TABLE 636            GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            443

TABLE 637            KINGDOM OF SAUDI ARABIA: KEY MACRO INDICATORS      444

TABLE 638            KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            444

TABLE 639            KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            444

TABLE 640            KINGDOM OF SAUDI ARABIA: VETERINARY IMMUNODIAGNOSTICS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         445

TABLE 641            KINGDOM OF SAUDI ARABIA: VETERINARY LATERAL FLOW ASSAYS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         445

TABLE 642            KINGDOM OF SAUDI ARABIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET,

BY TYPE, 2023–2030 (USD MILLION)         446

TABLE 643            KINGDOM OF SAUDI ARABIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)            446

TABLE 644            KINGDOM OF SAUDI ARABIA: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            446

TABLE 645            KINGDOM OF SAUDI ARABIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         447

TABLE 646            KINGDOM OF SAUDI ARABIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         447

TABLE 647            KINGDOM OF SAUDI ARABIA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)                 447

TABLE 648            KINGDOM OF SAUDI ARABIA: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            448

TABLE 649            KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            448

TABLE 650            KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            448

TABLE 651            KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 449

TABLE 652            KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            449

TABLE 653            KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)            449

TABLE 654            KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            450

TABLE 655            UNITED ARAB EMIRATES: KEY MACRO INDICATORS      450

TABLE 656            UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            451

TABLE 657            UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            451

TABLE 658            UNITED ARAB EMIRATES: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)            452

TABLE 659            UNITED ARAB EMIRATES: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)            452

TABLE 660            UNITED ARAB EMIRATES: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)            453

TABLE 661            UNITED ARAB EMIRATES: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)            453

TABLE 662            UNITED ARAB EMIRATES: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            453

TABLE 663            UNITED ARAB EMIRATES: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)            454

TABLE 664            UNITED ARAB EMIRATES: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)            454

TABLE 665            UNITED ARAB EMIRATES: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            454

TABLE 666            UNITED ARAB EMIRATES: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            455

TABLE 667            UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            455

TABLE 668            UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            455

TABLE 669            UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 456

TABLE 670            UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            456

TABLE 671            UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)            457

TABLE 672            UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            457

TABLE 673            OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            458

TABLE 674            OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            458

TABLE 675            OTHER GCC COUNTRIES: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)            459

TABLE 676            OTHER GCC COUNTRIES: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)            459

TABLE 677            OTHER GCC COUNTRIES: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)            460

TABLE 678            OTHER GCC COUNTRIES: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)            460

TABLE 679            OTHER GCC COUNTRIES: GLUCOSE MONITORING MARKET, BY TYPE,

2023–2030 (USD MILLION)            460

TABLE 680            OTHER GCC COUNTRIES: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)            461

TABLE 681            OTHER GCC COUNTRIES: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)            461

TABLE 682            OTHER GCC COUNTRIES: VETERINARY HEMATOLOGY MARKET, BY TYPE,

2023–2030 (USD MILLION)            461

TABLE 683            OTHER GCC COUNTRIES: VETERINARY URINALYSIS MARKET, BY TYPE,

2023–2030 (USD MILLION)            462

TABLE 684            OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            462

TABLE 685            OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            462

TABLE 686            OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,

BY TYPE, 2023–2030 (USD MILLION)         463

TABLE 687            OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            463

TABLE 688            OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)            464

TABLE 689            OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            464

TABLE 690            REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            465

TABLE 691            REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            465

TABLE 692            REST OF MIDDLE EAST & AFRICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)            466

TABLE 693            REST OF MIDDLE EAST & AFRICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)            466

TABLE 694            REST OF MIDDLE EAST & AFRICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)            467

TABLE 695            REST OF MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)            467

TABLE 696            REST OF MIDDLE EAST & AFRICA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)                 467

TABLE 697            REST OF MIDDLE EAST & AFRICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)            468

TABLE 698            REST OF MIDDLE EAST & AFRICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)            468

TABLE 699            REST OF MIDDLE EAST & AFRICA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)                 468

TABLE 700            REST OF MIDDLE EAST & AFRICA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 469

TABLE 701            REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            469

TABLE 702            REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            469

TABLE 703            REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 470

TABLE 704            REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            470

TABLE 705            REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)            471

TABLE 706            REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET,

BY END USER, 2023–2030 (USD MILLION)               471

TABLE 707            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET            472

TABLE 708            VETERINARY DIAGNOSTICS MARKET: DEGREE OF COMPETITION           475

TABLE 709            VETERINARY DIAGNOSTICS MARKET: REGION FOOTPRINT       480

TABLE 710            VETERINARY DIAGNOSTIC MARKET: PRODUCT FOOTPRINT       481

TABLE 711            VETERINARY DIAGNOSTICS MARKET: TECHNOLOGY FOOTPRINT        482

TABLE 712            VETERINARY DIAGNOSTIC MARKET: ANIMAL TYPE FOOTPRINT            483

TABLE 713            VETERINARY DIAGNOSTIC MARKET: DETAILED LIST OF KEY STARTUPS/SMES   486

TABLE 714            VETERINARY DIAGNOSTIC MARKET: COMPETITIVE BENCHMARKING OF STARTUPS 487

TABLE 715            VETERINARY DIAGNOSTIC MARKET: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025    490

TABLE 716            VETERINARY DIAGNOSTICS MARKET: DEALS, JANUARY 2022–MAY 2025               492

TABLE 717            VETERINARY DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2022–MAY 2025  492

TABLE 718            VETERINARY DIAGNOSTIC MARKET: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025    493

TABLE 719            IDEXX LABORATORIES, INC.: COMPANY OVERVIEW          494

TABLE 720            IDEXX LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED               495

TABLE 721            IDEXX LABORATORIES, INC.: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025    500

TABLE 722            ZOETIS SERVICES LLC: COMPANY OVERVIEW                 503

TABLE 723            ZOETIS SERVICES LLC: PRODUCTS/SERVICES OFFERED             504

TABLE 724            ZOETIS SERVICES LLC: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025              506

TABLE 725            ZOETIS SERVICES LLC: DEALS, JANUARY 2022–APRIL 2025           507

TABLE 726            ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022–MAY 2025   507

TABLE 727            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          509

TABLE 728            THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED               510

TABLE 729            ANTECH DIAGNOSTICS, INC.: COMPANY OVERVIEW          518

TABLE 730            ANTECH DIAGNOSTICS, INC.: PRODUCTS/SERVICES OFFERED               518

TABLE 731            ANTECH DIAGNOSTICS, INC.: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025    519

TABLE 732            ANTECH DIAGNOSTICS, INC.: EXPANSIONS, JANUARY 2022–MAY 2025               520

TABLE 733            BIOMÉRIEUX: COMPANY OVERVIEW      521

TABLE 734            BIOMÉRIEUX: PRODUCTS/SERVICES OFFERED                 522

TABLE 735            BIOMÉRIEUX: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025                 523

TABLE 736            NEOGEN CORPORATION: COMPANY OVERVIEW          525

TABLE 737            NEOGEN CORPORATION: PRODUCTS/SERVICES OFFERED               526

TABLE 738            NEOGEN CORPORATION: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025              528

TABLE 739            NEOGEN CORPORATION: DEALS, JANUARY 2022–MAY 2025   529

TABLE 740            NEOGEN CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025          529

TABLE 741            BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW          530

TABLE 742            BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED               531

TABLE 743            VIRBAC: COMPANY OVERVIEW 533

TABLE 744            VIRBAC: PRODUCTS/SERVICES OFFERED                 534

TABLE 745            VIRBAC: DEALS, JANUARY 2022–MAY 2025                 535

TABLE 746            VIRBAC: EXPANSIONS, JANUARY 2022–MAY 2025                 536

TABLE 747            FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW   537

TABLE 748            FUJIFILM HOLDINGS CORPORATION: PRODUCTS/SERVICES OFFERED               538

TABLE 749            SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.:

COMPANY OVERVIEW   539

TABLE 750            SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS/SERVICES OFFERED                 540

TABLE 751            SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS,

JANUARY 2022–MAY 2025               541

TABLE 752            SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.:

EXPANSIONS, JANUARY 2022–MAY 2025  541

TABLE 753            INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW          542

TABLE 754            INDICAL BIOSCIENCE: PRODUCTS/SERVICES OFFERED             542

TABLE 755            INDICAL BIOSCIENCE GMBH: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025    545

TABLE 756            BIONOTE: COMPANY OVERVIEW              546

TABLE 757            BIONOTE: PRODUCTS/SERVICES OFFERED                 546

TABLE 758            BIONOTE: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025                 549

TABLE 759            BIONOTE: DEALS, JANUARY 2022–MAY 2025                 550

TABLE 760            BIOGAL: COMPANY OVERVIEW 551

TABLE 761            BIOGAL: PRODUCTS/SERVICES OFFERED                 551

TABLE 762            AGROLABO S.P.A.: COMPANY OVERVIEW                 553

TABLE 763            AGROLABO S.P.A.: PRODUCTS/SERVICES OFFERED             553

TABLE 764            INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW          558

TABLE 765            INNOVATIVE DIAGNOSTICS: PRODUCTS/SERVICES OFFERED               558

TABLE 766            RANDOX LABORATORIES LTD.: COMPANY OVERVIEW          566

TABLE 767            BIOCHEK: COMPANY OVERVIEW              567

TABLE 768            FASSISI, GMBH: COMPANY OVERVIEW   568

TABLE 769            ALVEDIA: COMPANY OVERVIEW               569

TABLE 770            SKYER, INC.: COMPANY OVERVIEW         570

TABLE 771            SHENZHEN BIOEASY BIOTECHNOLOGY, INC.: COMPANY OVERVIEW   571

TABLE 772            PRECISION BIOSENSOR, INC.: COMPANY OVERVIEW          572

TABLE 773            EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: COMPANY OVERVIEW              573

TABLE 774            GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW          574

TABLE 775            SKYLA CORPORATION: COMPANY OVERVIEW                 575

LIST OF FIGURES

FIGURE 1              VETERINARY DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SPREAD 48

FIGURE 2              VETERINARY DIAGNOSTICS MARKET: RESEARCH DESIGN         51

FIGURE 3              PRIMARY SOURCES         53

FIGURE 4              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)                 55

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (DEMAND SIDE)                 56

FIGURE 6              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS            56

FIGURE 7              SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS         57

FIGURE 8              REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.       57

FIGURE 9              REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY

DIAGNOSTICS MARKET (2024)   58

FIGURE 10            VETERINARY DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS             59

FIGURE 11            CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY DIAGNOSTICS MARKET (2025–2030)              60

FIGURE 12            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 61

FIGURE 13            TOP-DOWN APPROACH                62

FIGURE 14            BOTTOM-UP APPROACH              62

FIGURE 15            MARKET DATA TRIANGULATION METHODOLOGY              63

FIGURE 16            VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)               66

FIGURE 17            VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,

2025 VS. 2030 (USD MILLION)      67

FIGURE 18            VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2025 VS. 2030 (USD MILLION)      67

FIGURE 19            VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,

2025 VS. 2030 (USD MILLION)      68

FIGURE 20            VETERINARY DIAGNOSTICS MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      69

FIGURE 21            GEOGRAPHIC SNAPSHOT OF VETERINARY DIAGNOSTICS MARKET 70

FIGURE 22            GROWING PREVALENCE OF ZOONOTIC DISEASES TO PROPEL MARKET 71

FIGURE 23            CONSUMABLES SEGMENT IN CHINA ACCOUNTED FOR LARGEST

MARKET SHARE IN 2024 72

FIGURE 24            ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD          73

FIGURE 25            CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       73

FIGURE 26            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD    74

FIGURE 27            VETERINARY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES         75

FIGURE 28            EUROPE: PET POPULATION, 2021–2023  77

FIGURE 29            US: PET EXPENDITURE, DOGS VS CATS, 2024 (USD)    81

FIGURE 30            PORTER’S FIVE FORCES ANALYSIS           92

FIGURE 31            VETERINARY DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–MAY 2025)      98

FIGURE 32            TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DIAGNOSTIC PATENTS (JANUARY 2014–MAY 2025)                 99

FIGURE 33            AVERAGE SELLING PRICE TREND FOR CLINICAL CHEMISTRY AND BLOOD GAS & ELECTROLYTE ANALYZERS, BY KEY PLAYER, 2024             103

FIGURE 34            AVERAGE SELLING PRICE FOR CLINICAL CHEMISTRY ANALYZERS AND BLOOD GAS & ELECTROLYTE ANALYZERS, BY REGION, 2024    104

FIGURE 35            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTICS          108

FIGURE 36            KEY BUYING CRITERIA FOR TOP THREE END USERS   109

FIGURE 37            AI-USE CASES    111

FIGURE 38            VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP          112

FIGURE 39            VETERINARY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS              114

FIGURE 40            VETERINARY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS              115

FIGURE 41            VETERINARY DIAGNOSTICS MARKET: ADJACENT MARKETS     116

FIGURE 42            VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT            255

FIGURE 43            EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA    256

FIGURE 44            NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET SNAPSHOT       257

FIGURE 45            ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024 334

FIGURE 46            ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024 334

FIGURE 47            ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET SNAPSHOT       335

FIGURE 48            REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET (2022–2024)              474

FIGURE 49            MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET (2024)        475

FIGURE 50            RANKING OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET, 2024      476

FIGURE 51            VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2024  478

FIGURE 52            VETERINARY DIAGNOSTICS MARKET: COMPANY FOOTPRINT 479

FIGURE 53            VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024                 485

FIGURE 54            VETERINARY DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     488

FIGURE 55            R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY DIAGNOSTICS

MARKET, 2022–2024          489

FIGURE 56            EV/EBITDA OF KEY VENDORS   489

FIGURE 57            YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK

BETA OF KEY VENDORS                490

FIGURE 58            IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024)             495

FIGURE 59            ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2024)    504

FIGURE 60            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)             510

FIGURE 61            BIOMÉRIEUX: COMPANY SNAPSHOT (2024)                 522

FIGURE 62            NEOGEN CORPORATION: COMPANY SNAPSHOT (2024)             526

FIGURE 63            BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)             531

FIGURE 64            VIRBAC: COMPANY SNAPSHOT (2024)    534

FIGURE 65            FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2024)      538

FIGURE 66            SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.:

COMPANY SNAPSHOT (2024)      540

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧